Latest On-Demand Webinars

Cell-to-cell communication in cancer is pivotal for tumor progression, metastasis, and treatment resistance. This complex network of signalling pathways allows cancer cells to interact, shaping their behavior and response to therapy.

This webinar will review how kinetic characterization of biological interactions can guide the selection of best-in-class detector molecules to enhance lateral flow diagnostics and outline the benefits of characterizing and selecting your lateral flow antibodies using SPR technology.

Raw materials identification (RMID) is a crucial regulatory step required before drug manufacturing. Raman spectroscopy is well-suited to making the process simpler, yet some spectrometers are challenged by light-blocking containers or struggle to reach compliance standards.

Cell and gene therapies harness the power of cells or genetic material to treat, cure or prevent diseases. These cutting-edge therapeutics have the potential to revolutionize medical treatments, especially for conditions that were previously thought to be incurable, including genetic disorders, cancer and degenerative conditions.

Dr. Yuan Liu from Indiana University will be joining Technology Networks to provide a comprehensive overview of this promising field, paving the way for potential therapeutics.

Join us for an exclusive opportunity to speak directly with Dr. David Baltimore, a distinguished figure in this field and a Nobel Laureate, as he navigates the complexities of CRISPR genome editing technology.

Generating a highly expressing, regulatory compliant clonal cell line is key when developing a biopharmaceutical. Yet cell line development is labor-intensive, time consuming and costly.

The production of a high-quality and productive cell line requires both an expression system which yields high expressing clones and a workflow which allows selection of the highest producing clones.

In this webinar, you’ll discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary (GS-CHO) expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.

To ensure the safety and efficacy of LNP-based drugs, comprehensive characterization of these sophisticated molecules–the lipids and the genetic cargo–is paramount.

Cell therapies often involve introduction of genetically transformed cells into a patient. Recently there has been renewed interest in non-viral gene modification for this application as an alternative to lentiviral vectors.

This exclusive Q&A event invites you to ask anything about the world of predatory conferences to our expert speaker.